Medx Health Corp V.MDX

Disappointment Continues

[hobbs2969]

Wow.  With 208 000 shares bid at 12.5 cents and 266 000 shares at 12 cents, it looks like people are trying to bring MDX to its knees. On the ask side, there are 16 500 shares for sale at 13 cents and 10 000 shares at 13.5 cents.  At the end of today, I wonder who will win the battle.

[Eastmk]

I think we all know the answer to that question. Not looking good at all.

[Insightful1]

My read on this is quite simple, MedX has promised a strong Q3-4 if you go back and listen to the interviews. There are a lot of shareholders who rightfully are impatient with the progress in MedX producing revenue and are selling their position. Compared to a company like DermTech, MedX is in much better position to dominate the skin cancer screening market. DermTech technology only captures

[Dunworkin2]

The trouble is that these guys have been missing 99% of their comments made via youtube and no investor knows what the heck this means: "MedX has promised a strong Q3-4", apparently you have a good idea, please share what revenue range you think Medx will hit in Q3. Their acting CEO is on record as stating they don't provide forward guidance. Heck, he seemed to be happy with Q1

[Insightful1]

I think your question is perfectly framed. MedX needs to demonstrate they are getting market traction in high volume scanning centres. They have 8 high volume scanning centres running in the Netherlands. The reason you need these is to reduce the burn. MedX has 11 centres open in Canada and with Ontario opening up we should see those centres have high volume because of the long wait times in

[hopefull]

I think at this point trying to compare Medx with derm tech is ridiculous at this point.bthey are at least earning investors money and communicating. They have money coming in granted low and can't justify the return, however they have built a reputation. Medx also has built a reputation for for casting greatness into the future.still have not produced any results that we can visually see in

[Insightful1]

I think MedX is executing on their strategy that I laid out on my earlier post. I think DermTech shares traded from Aug,2017- Dec 2020 from $19.40-$11.49 loosing lots of money. Then they announced their platform with a few clinical papers and their shares took off. Last quarter they lost $15.1 million so I think your statements earning investors money are a bit misguided.If you are referring to

[hopefull]

I have gotten through spoke to Mike and Adrian. They really can't share any new information or any new financial information. Bill stated it would be great to have a monthly statement showing how many scans on how many machines , as opposed to waiting on quarterly finacials. Equally he did state that communication from Medx is extremely poor and needs to be rectified,also has great concern of

[1stockwatcher]

It's not the Q3-4 that is the issue, it is the year. MDX has frequently given the impression that in the next 6-9 months they will see the dollars rolling in. So far none has shown up. If you could clarify Q3-4 of which year that would be helpful.